{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,27]],"date-time":"2026-10-27T02:19:48Z","timestamp":1793067588980,"version":"4.5.0"},"reference-count":83,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2024,9,16]],"date-time":"2024-09-16T00:00:00Z","timestamp":1726444800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2024,9,16]],"date-time":"2024-09-16T00:00:00Z","timestamp":1726444800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Nat Commun"],"DOI":"10.1038\/s41467-024-52400-8","type":"journal-article","created":{"date-parts":[[2024,9,18]],"date-time":"2024-09-18T08:20:54Z","timestamp":1726647654000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":22,"title":["Ready-to-use iPSC-derived microglia progenitors for the treatment of CNS disease in mouse models of neuropathic mucopolysaccharidoses"],"prefix":"10.1038","volume":"15","author":[{"given":"Panagiotis","family":"Douvaras","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Diego F.","family":"Buenaventura","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bruce","family":"Sun","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ashley","family":"Lepack","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Elizabeth","family":"Baker","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Elizabeth","family":"Simpson","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mark","family":"Ebel","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gregory","family":"Lallos","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Deven","family":"LoSchiavo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nicholas","family":"Stitt","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nathaniel","family":"Adams","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Conor","family":"McAuliffe","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ana","family":"Forton-Juarez","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Brian","family":"Kosmyna","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Elizabeth","family":"Pereira","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Benjamin","family":"Burnett","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"David","family":"Dilworth","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Stephanie","family":"Fisher","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jing","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Peter","family":"Tonge","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mark","family":"Tomishima","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Carlos","family":"Paladini","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dan","family":"Wilkinson","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chew-Li","family":"Soh","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Maya","family":"Srinivas","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Christoph","family":"Patsch","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-0482-714X","authenticated-orcid":false,"given":"Stefan","family":"Irion","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2024,9,16]]},"reference":[{"key":"52400_CR1","unstructured":"Rajkumar, V. & Dumpa, V. Lysosomal Storage Disease. in StatPearls (StatPearls Publishing, Treasure Island (FL), 2022)."},{"key":"52400_CR2","doi-asserted-by":"publisher","first-page":"8","DOI":"10.1016\/j.ymgme.2021.03.002","volume":"133","author":"EG Shapiro","year":"2021","unstructured":"Shapiro, E. G. & Eisengart, J. B. The natural history of neurocognition in MPS disorders: A review. Mol. Genet Metab. 133, 8\u201334 (2021).","journal-title":"Mol. Genet Metab."},{"key":"52400_CR3","unstructured":"Valle, D. J., Antonarakis, S., Ballabio, A., Beaudet, A. L. & Mitchell, G. A. The Online Metabolic and Molecular Bases of Inherited Disease | OMMBID | McGraw Hill Medical. https:\/\/ommbid.mhmedical.com\/book.aspx?bookID=2709#225069487."},{"key":"52400_CR4","doi-asserted-by":"crossref","unstructured":"Jb, E. et al. Long-term cognitive and somatic outcomes of enzyme replacement therapy in untransplanted Hurler syndrome. Molecular genetics and metabolism reports 13, 64\u201368 (2017).","DOI":"10.1016\/j.ymgmr.2017.07.012"},{"key":"52400_CR5","unstructured":"Clarke, L. A. Mucopolysaccharidosis Type I. in GeneReviews\u00ae (eds. Adam, M. P. et al.) (University of Washington, Seattle, Seattle (WA), 1993)."},{"key":"52400_CR6","doi-asserted-by":"publisher","first-page":"559804","DOI":"10.3389\/fmolb.2020.559804","volume":"7","author":"MJ Edelmann","year":"2020","unstructured":"Edelmann, M. J. & Maegawa, G. H. B. CNS-targeting therapies for lysosomal storage diseases: current advances and challenges. Front Mol. Biosci. 7, 559804 (2020).","journal-title":"Front Mol. Biosci."},{"key":"52400_CR7","doi-asserted-by":"publisher","first-page":"285","DOI":"10.1055\/s-0036-1584602","volume":"47","author":"JJ Boelens","year":"2016","unstructured":"Boelens, J. J. & van Hasselt, P. M. Neurodevelopmental outcome after hematopoietic cell transplantation in inborn errors of metabolism: current considerations and future perspectives. Neuropediatrics 47, 285\u2013292 (2016).","journal-title":"Neuropediatrics"},{"key":"52400_CR8","doi-asserted-by":"publisher","first-page":"339","DOI":"10.1056\/NEJMsa1311707","volume":"371","author":"L Gragert","year":"2014","unstructured":"Gragert, L. et al. HLA match likelihoods for hematopoietic stem-cell grafts in the U.S. Registry. N. Engl. J. Med. 371, 339\u2013348 (2014).","journal-title":"N. Engl. J. Med."},{"key":"52400_CR9","doi-asserted-by":"publisher","first-page":"570","DOI":"10.1126\/science.162.3853.570","volume":"162","author":"JC Fratantoni","year":"1968","unstructured":"Fratantoni, J. C., Hall, C. W. & Neufeld, E. F. Hurler and Hunter syndromes: mutual correction of the defect in cultured fibroblasts. Science 162, 570\u2013572 (1968).","journal-title":"Science"},{"key":"52400_CR10","doi-asserted-by":"crossref","unstructured":"Ginhoux, F., Lim, S., Hoeffel, G., Low, D. & Huber, T. Origin and differentiation of microglia. Front. Cell. Neurosci. 7, 1662\u20135102 (2013).","DOI":"10.3389\/fncel.2013.00045"},{"key":"52400_CR11","doi-asserted-by":"publisher","first-page":"1358","DOI":"10.1038\/nm.4189","volume":"22","author":"J Muffat","year":"2016","unstructured":"Muffat, J. et al. Efficient derivation of microglia-like cells from human pluripotent stem cells. Nat. Med. 22, 1358\u20131367 (2016).","journal-title":"Nat. Med"},{"key":"52400_CR12","doi-asserted-by":"crossref","unstructured":"McQuade, A. et al. Development and validation of a simplified method to generate human microglia from pluripotent stem cells. Mol. Neurodegen. 13, 67 (2018).","DOI":"10.1186\/s13024-018-0297-x"},{"key":"52400_CR13","doi-asserted-by":"publisher","first-page":"753","DOI":"10.1038\/nn.4534","volume":"20","author":"H Pandya","year":"2017","unstructured":"Pandya, H. et al. Differentiation of human and murine induced pluripotent stem cells to microglia-like cells. Nat. Neurosci. 20, 753\u2013759 (2017).","journal-title":"Nat. Neurosci."},{"key":"52400_CR14","doi-asserted-by":"publisher","first-page":"1516","DOI":"10.1016\/j.stemcr.2017.04.023","volume":"8","author":"P Douvaras","year":"2017","unstructured":"Douvaras, P. et al. Directed differentiation of human pluripotent stem cells to microglia. Stem Cell Rep. 8, 1516\u20131524 (2017).","journal-title":"Stem Cell Rep."},{"key":"52400_CR15","doi-asserted-by":"publisher","first-page":"278","DOI":"10.1016\/j.neuron.2017.03.042","volume":"94","author":"EM Abud","year":"2017","unstructured":"Abud, E. M. et al. iPSC-derived human microglia-like cells to study neurological diseases. Neuron 94, 278\u2013293.e9 (2017).","journal-title":"Neuron"},{"key":"52400_CR16","doi-asserted-by":"publisher","DOI":"10.1038\/srep19371","volume":"6","author":"J Rustenhoven","year":"2016","unstructured":"Rustenhoven, J. et al. Isolation of highly enriched primary human microglia for functional studies. Sci. Rep. 6, 19371 (2016).","journal-title":"Sci. Rep."},{"key":"52400_CR17","doi-asserted-by":"publisher","first-page":"571","DOI":"10.1038\/s41586-020-2316-7","volume":"582","author":"Z Bian","year":"2020","unstructured":"Bian, Z. et al. Deciphering human macrophage development at single-cell resolution. Nature 582, 571\u2013576 (2020).","journal-title":"Nature"},{"key":"52400_CR18","doi-asserted-by":"publisher","first-page":"86","DOI":"10.1126\/science.1219179","volume":"336","author":"C Schulz","year":"2012","unstructured":"Schulz, C. et al. A lineage of myeloid cells independent of Myb and hematopoietic stem cells. Science 336, 86\u201390 (2012).","journal-title":"Science"},{"key":"52400_CR19","doi-asserted-by":"publisher","unstructured":"Svoboda, D. S. et al. Human iPSC-derived microglia assume a primary microglia-like state after transplantation into the neonatal mouse brain. Proc. Natl Acad. Sci. USA 201913541 https:\/\/doi.org\/10.1073\/pnas.1913541116 (2019).","DOI":"10.1073\/pnas.1913541116"},{"key":"52400_CR20","doi-asserted-by":"publisher","first-page":"907","DOI":"10.1172\/JCI107830","volume":"54","author":"R Matalon","year":"1974","unstructured":"Matalon, R. & Dorfman, A. Sanfilippo A Syndrome sulfamidase deficiency in cultured skin fibroblasts and liver. J. Clin. Invest. 54, 907\u2013912 (1974).","journal-title":"J. Clin. Invest."},{"key":"52400_CR21","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/S0006-291X(74)80349-9","volume":"57","author":"FE Brot","year":"1974","unstructured":"Brot, F. E., Glaser, J. H., Roozen, K. J., Sly, W. S. & Stahl, P. D. In vitro correction of deficient human fibroblasts by beta-glucuronidase from different human sources. Biochem. Biophys. Res. Commun. 57, 1\u20138 (1974).","journal-title":"Biochem. Biophys. Res. Commun."},{"key":"52400_CR22","doi-asserted-by":"publisher","first-page":"2764","DOI":"10.1046\/j.1432-1033.2002.02951.x","volume":"269","author":"P Di Natale","year":"2002","unstructured":"Di Natale, P. et al. In vitro gene therapy of mucopolysaccharidosis type I by lentiviral vectors. Eur. J. Biochem. 269, 2764\u20132771 (2002).","journal-title":"Eur. J. Biochem."},{"key":"52400_CR23","doi-asserted-by":"publisher","first-page":"495","DOI":"10.1016\/j.mam.2006.08.005","volume":"27","author":"E-L Eskelinen","year":"2006","unstructured":"Eskelinen, E.-L. Roles of LAMP-1 and LAMP-2 in lysosome biogenesis and autophagy. Mol. Asp. Med. 27, 495\u2013502 (2006).","journal-title":"Mol. Asp. Med."},{"key":"52400_CR24","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1038\/s41392-021-00778-y","volume":"6","author":"M Cao","year":"2021","unstructured":"Cao, M., Luo, X., Wu, K. & He, X. Targeting lysosomes in human disease: from basic research to clinical applications. Sig Transduct. Target Ther. 6, 1\u201328 (2021).","journal-title":"Sig Transduct. Target Ther."},{"key":"52400_CR25","doi-asserted-by":"publisher","first-page":"542","DOI":"10.1016\/j.ymgme.2011.12.012","volume":"105","author":"MF Coutinho","year":"2012","unstructured":"Coutinho, M. F., Prata, M. J. & Alves, S. Mannose-6-phosphate pathway: a review on its role in lysosomal function and dysfunction. Mol. Genet Metab. 105, 542\u2013550 (2012).","journal-title":"Mol. Genet Metab."},{"key":"52400_CR26","doi-asserted-by":"publisher","first-page":"257","DOI":"10.1016\/j.ymgme.2012.07.012","volume":"107","author":"MF Coutinho","year":"2012","unstructured":"Coutinho, M. F., Prata, M. J. & Alves, S. A shortcut to the lysosome: The mannose-6-phosphate-independent pathway. Mol. Genet. Metab. 107, 257\u2013266 (2012).","journal-title":"Mol. Genet. Metab."},{"key":"52400_CR27","doi-asserted-by":"publisher","unstructured":"Hasselmann, J. et al. Development of a chimeric model to study and manipulate human microglia in vivo. Neuron S0896627319306002 https:\/\/doi.org\/10.1016\/j.neuron.2019.07.002 (2019).","DOI":"10.1016\/j.neuron.2019.07.002"},{"key":"52400_CR28","doi-asserted-by":"publisher","first-page":"23","DOI":"10.1016\/j.pediatrneurol.2016.10.022","volume":"67","author":"JL Cohen-Pfeffer","year":"2017","unstructured":"Cohen-Pfeffer, J. L. et al. Intracerebroventricular delivery as a safe, long-term route of drug administration. Pediatr. Neurol. 67, 23\u201335 (2017).","journal-title":"Pediatr. Neurol."},{"key":"52400_CR29","doi-asserted-by":"publisher","first-page":"557","DOI":"10.1016\/j.cell.2020.03.021","volume":"181","author":"SG Utz","year":"2020","unstructured":"Utz, S. G. et al. Early fate defines microglia and non-parenchymal brain macrophage development. Cell 181, 557\u2013573.e18 (2020).","journal-title":"Cell"},{"key":"52400_CR30","doi-asserted-by":"publisher","first-page":"180","DOI":"10.4049\/jimmunol.154.1.180","volume":"154","author":"LD Shultz","year":"1995","unstructured":"Shultz, L. D. et al. Multiple defects in innate and adaptive immunologic function in NOD\/LtSz-scid mice. J. Immunol. 154, 180\u2013191 (1995).","journal-title":"J. Immunol."},{"key":"52400_CR31","doi-asserted-by":"publisher","first-page":"380","DOI":"10.1016\/j.immuni.2018.01.011","volume":"48","author":"D Mrdjen","year":"2018","unstructured":"Mrdjen, D. et al. High-dimensional single-cell mapping of central nervous system immune cells reveals distinct myeloid subsets in health, aging, and disease. Immunity 48, 380\u2013395.e6 (2018).","journal-title":"Immunity"},{"key":"52400_CR32","doi-asserted-by":"publisher","first-page":"1021","DOI":"10.1038\/s41593-019-0393-4","volume":"22","author":"H Van Hove","year":"2019","unstructured":"Van Hove, H. et al. A single-cell atlas of mouse brain macrophages reveals unique transcriptional identities shaped by ontogeny and tissue environment. Nat. Neurosci. 22, 1021\u20131035 (2019).","journal-title":"Nat. Neurosci."},{"key":"52400_CR33","doi-asserted-by":"publisher","first-page":"294","DOI":"10.4049\/jimmunol.1900821","volume":"204","author":"S Brioschi","year":"2020","unstructured":"Brioschi, S., Zhou, Y. & Colonna, M. Brain Parenchymal and Extraparenchymal macrophages in development, homeostasis, and disease. J. Immunol. 204, 294\u2013305 (2020).","journal-title":"J. Immunol."},{"key":"52400_CR34","doi-asserted-by":"publisher","DOI":"10.1038\/s41467-020-15411-9","volume":"11","author":"R Xu","year":"2020","unstructured":"Xu, R. et al. Human iPSC-derived mature microglia retain their identity and functionally integrate in the chimeric mouse brain. Nat. Commun. 11, 1577 (2020).","journal-title":"Nat. Commun."},{"key":"52400_CR35","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/j.pneurobio.2013.04.001","volume":"106\u2013107","author":"BD Semple","year":"2013","unstructured":"Semple, B. D., Blomgren, K., Gimlin, K., Ferriero, D. M. & Noble-Haeusslein, L. J. Brain development in rodents and humans: Identifying benchmarks of maturation and vulnerability to injury across species. Prog. Neurobiol. 106\u2013107, 1\u201316 (2013).","journal-title":"Prog. Neurobiol."},{"key":"52400_CR36","doi-asserted-by":"publisher","first-page":"65","DOI":"10.1016\/j.ymgme.2020.02.009","volume":"130","author":"J Cadaoas","year":"2020","unstructured":"Cadaoas, J. et al. Vestronidase alfa: Recombinant human \u03b2-glucuronidase as an enzyme replacement therapy for MPS VII. Mol. Genet Metab. 130, 65\u201376 (2020).","journal-title":"Mol. Genet Metab."},{"key":"52400_CR37","doi-asserted-by":"publisher","first-page":"241","DOI":"10.1016\/j.brainres.2007.10.036","volume":"1188","author":"D Pan","year":"2008","unstructured":"Pan, D., Sciascia, A., Vorhees, C. V. & Williams, M. T. Progression of multiple behavioral deficits with various age of onset in a murine model of Hurler Syndrome. Brain Res. 1188, 241\u2013253 (2008).","journal-title":"Brain Res"},{"key":"52400_CR38","doi-asserted-by":"publisher","first-page":"2028","DOI":"10.1038\/mt.2014.152","volume":"22","author":"SS El-Amouri","year":"2014","unstructured":"El-Amouri, S. S., Dai, M., Han, J.-F., Brady, R. O. & Pan, D. Normalization and improvement of CNS deficits in mice with hurler syndrome after long-term peripheral delivery of BBB-targeted Iduronidase. Mol. Ther. 22, 2028\u20132037 (2014).","journal-title":"Mol. Ther."},{"key":"52400_CR39","doi-asserted-by":"publisher","unstructured":"Guyenet, S. J. et al. A simple composite phenotype scoring system for evaluating mouse models of cerebellar Ataxia. J. Vis. Exp. 1787 https:\/\/doi.org\/10.3791\/1787 (2010).","DOI":"10.3791\/1787"},{"key":"52400_CR40","doi-asserted-by":"publisher","first-page":"149","DOI":"10.1002\/mdc3.12573","volume":"5","author":"D Ebrahimi\u2010Fakhari","year":"2018","unstructured":"Ebrahimi\u2010Fakhari, D. et al. The spectrum of movement disorders in childhood\u2010onset lysosomal storage diseases. Mov. Disord. Clin. Pr. 5, 149\u2013155 (2018).","journal-title":"Mov. Disord. Clin. Pr."},{"key":"52400_CR41","doi-asserted-by":"publisher","first-page":"2164","DOI":"10.1182\/blood-2014-11-608075","volume":"125","author":"M Aldenhoven","year":"2015","unstructured":"Aldenhoven, M. et al. Long-term outcome of Hurler syndrome patients after hematopoietic cell transplantation: an international multicenter study. Blood 125, 2164\u20132172 (2015).","journal-title":"Blood"},{"key":"52400_CR42","doi-asserted-by":"publisher","first-page":"63","DOI":"10.1016\/j.ymgme.2013.11.015","volume":"111","author":"J Muenzer","year":"2014","unstructured":"Muenzer, J. Early initiation of enzyme replacement therapy for the mucopolysaccharidoses. Mol. Genet. Metab. 111, 63\u201372 (2014).","journal-title":"Mol. Genet. Metab."},{"key":"52400_CR43","doi-asserted-by":"crossref","first-page":"64","DOI":"10.1016\/j.ymgmr.2017.07.012","volume":"13","author":"JB Eisengart","year":"2017","unstructured":"Eisengart, J. B. et al. Long-term cognitive and somatic outcomes of enzyme replacement therapy in untransplanted Hurler syndrome. Mol. Genet Metab. Rep. 13, 64\u201368 (2017).","journal-title":"Mol. Genet Metab. Rep."},{"key":"52400_CR44","doi-asserted-by":"crossref","unstructured":"de Vasconcelos, P. & Lacerda, J. F. Hematopoietic stem cell transplantation for neurological disorders: a focus on inborn errors of metabolism. Front. Cell. Neurosci. 16, 1662\u20135102 (2022).","DOI":"10.3389\/fncel.2022.895511"},{"key":"52400_CR45","doi-asserted-by":"publisher","first-page":"747","DOI":"10.1002\/ana.24246","volume":"76","author":"MD Poe","year":"2014","unstructured":"Poe, M. D., Chagnon, S. L. & Escolar, M. L. Early treatment is associated with improved cognition in Hurler syndrome. Ann. Neurol. 76, 747\u2013753 (2014).","journal-title":"Ann. Neurol."},{"key":"52400_CR46","doi-asserted-by":"publisher","first-page":"476","DOI":"10.1016\/S0140-6736(16)30374-9","volume":"388","author":"M Sessa","year":"2016","unstructured":"Sessa, M. et al. Lentiviral haemopoietic stem-cell gene therapy in early-onset metachromatic leukodystrophy: an ad-hoc analysis of a non-randomised, open-label, phase 1\/2 trial. Lancet 388, 476\u2013487 (2016).","journal-title":"Lancet"},{"key":"52400_CR47","doi-asserted-by":"publisher","unstructured":"Leone, M. A. et al. Foetal Allogeneic Intracerebroventricular Neural Stem Cell Transplantation in People with Secondary Progressive Multiple Sclerosis: A phase I dose-escalation clinical trial. 2022.11.14.22282124 Preprint at https:\/\/doi.org\/10.1101\/2022.11.14.22282124 (2022).","DOI":"10.1101\/2022.11.14.22282124"},{"key":"52400_CR48","doi-asserted-by":"publisher","first-page":"5257","DOI":"10.1007\/s11033-019-04983-5","volume":"46","author":"C Duma","year":"2019","unstructured":"Duma, C. et al. Human intracerebroventricular (ICV) injection of autologous, non-engineered, adipose-derived stromal vascular fraction (ADSVF) for neurodegenerative disorders: results of a 3-year phase 1 study of 113 injections in 31 patients. Mol. Biol. Rep. 46, 5257\u20135272 (2019).","journal-title":"Mol. Biol. Rep."},{"key":"52400_CR49","doi-asserted-by":"publisher","DOI":"10.1186\/2045-8118-11-10","volume":"11","author":"T Brinker","year":"2014","unstructured":"Brinker, T., Stopa, E., Morrison, J. & Klinge, P. A new look at cerebrospinal fluid circulation. Fluids Barriers CNS 11, 10 (2014).","journal-title":"Fluids Barriers CNS"},{"key":"52400_CR50","first-page":"326","volume":"55","author":"GWM Bothe","year":"2005","unstructured":"Bothe, G. W. M., Bolivar, V. J., Vedder, M. J. & Geistfeld, J. G. Behavioral differences among fourteen inbred mouse strains commonly used as disease models. Comp. Med. 55, 326\u2013334 (2005).","journal-title":"Comp. Med."},{"key":"52400_CR51","doi-asserted-by":"publisher","first-page":"315","DOI":"10.1080\/01677060802357388","volume":"22","author":"CD Bryant","year":"2008","unstructured":"Bryant, C. D. et al. Behavioral differences among C57BL\/6 substrains: implications for transgenic and knockout studies. J. Neurogenet. 22, 315\u2013331 (2008).","journal-title":"J. Neurogenet."},{"key":"52400_CR52","doi-asserted-by":"publisher","first-page":"149","DOI":"10.1111\/j.1601-183x.2004.00064.x","volume":"3","author":"GWM Bothe","year":"2004","unstructured":"Bothe, G. W. M., Bolivar, V. J., Vedder, M. J. & Geistfeld, J. G. Genetic and behavioral differences among five inbred mouse strains commonly used in the production of transgenic and knockout mice. Genes Brain Behav. 3, 149\u2013157 (2004).","journal-title":"Genes Brain Behav."},{"key":"52400_CR53","unstructured":"Wagner, V. F. et al. University of Washington, Seattle, Seattle (WA), 1993)."},{"key":"52400_CR54","doi-asserted-by":"publisher","first-page":"1549","DOI":"10.1056\/NEJM199211263272202","volume":"327","author":"CR Freed","year":"1992","unstructured":"Freed, C. R. et al. Survival of implanted fetal dopamine cells and neurologic improvement 12 to 46 months after transplantation for Parkinson\u2019s disease. N. Engl. J. Med. 327, 1549\u20131555 (1992).","journal-title":"N. Engl. J. Med."},{"key":"52400_CR55","doi-asserted-by":"publisher","first-page":"710","DOI":"10.1056\/NEJM200103083441002","volume":"344","author":"CR Freed","year":"2001","unstructured":"Freed, C. R. et al. Transplantation of embryonic dopamine neurons for severe Parkinson\u2019s disease. N. Engl. J. Med. 344, 710\u2013719 (2001).","journal-title":"N. Engl. J. Med."},{"key":"52400_CR56","doi-asserted-by":"publisher","first-page":"217","DOI":"10.1016\/j.stem.2021.01.004","volume":"28","author":"J Piao","year":"2021","unstructured":"Piao, J. et al. Preclinical efficacy and safety of a human embryonic stem cell-derived midbrain dopamine progenitor product, MSK-DA01. Cell Stem Cell 28, 217\u2013229.e7 (2021).","journal-title":"Cell Stem Cell"},{"key":"52400_CR57","unstructured":"Therapeutics, BlueRock Phase 1 Study To Assess the Safety and Tolerability of Human Embryonic Stem Cell-Derived Midbrain Dopamine Neuron Cell Therapy (MSK-DA01) For Advanced Parkinson\u2019s Disease https:\/\/clinicaltrials.gov\/study\/NCT04802733 (2022)."},{"key":"52400_CR58","doi-asserted-by":"publisher","first-page":"1299","DOI":"10.1016\/j.stem.2023.08.014","volume":"30","author":"A Kirkeby","year":"2023","unstructured":"Kirkeby, A. et al. Preclinical quality, safety, and efficacy of a human embryonic stem cell-derived product for the treatment of Parkinson\u2019s disease, STEM-PD. Cell Stem Cell 30, 1299\u20131314.e9 (2023).","journal-title":"Cell Stem Cell"},{"key":"52400_CR59","unstructured":"The STEM-PD Clinical Trial. The STEM-PD Clinical Trial https:\/\/stem-pd.org\/."},{"key":"52400_CR60","unstructured":"Announcement of physician-initiated clinical trials for Parkinson\u2019s disease\uff5cNews & Events. CiRA | Center for iPS Cell Research and Application, Kyoto University http:\/\/www.cira.kyoto-u.ac.jp\/e."},{"key":"52400_CR61","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1038\/s42003-021-02237-4","volume":"4","author":"S Petrus-Reurer","year":"2021","unstructured":"Petrus-Reurer, S. et al. Immunological considerations and challenges for regenerative cellular therapies. Commun. Biol. 4, 1\u201316 (2021).","journal-title":"Commun. Biol."},{"key":"52400_CR62","doi-asserted-by":"publisher","unstructured":"Gene therapies for mucopolysaccharidoses - Rossi \u2212 2024 - Journal of Inherited Metabolic Disease - Wiley Online Library. https:\/\/doi.org\/10.1002\/jimd.12626.","DOI":"10.1002\/jimd.12626"},{"key":"52400_CR63","doi-asserted-by":"publisher","DOI":"10.1186\/s13023-018-0849-8","volume":"13","author":"R Giugliani","year":"2018","unstructured":"Giugliani, R. et al. Neurocognitive and somatic stabilization in pediatric patients with severe Mucopolysaccharidosis Type I after 52 weeks of intravenous brain-penetrating insulin receptor antibody-iduronidase fusion protein (valanafusp alpha): an open label phase 1-2 trial. Orphanet J. Rare Dis. 13, 110 (2018).","journal-title":"Orphanet J. Rare Dis."},{"key":"52400_CR64","doi-asserted-by":"publisher","first-page":"1477","DOI":"10.1038\/nbt1362","volume":"25","author":"S Irion","year":"2007","unstructured":"Irion, S. et al. Identification and targeting of the ROSA26 locus in human embryonic stem cells. Nat. Biotechnol. 25, 1477\u20131482 (2007).","journal-title":"Nat. Biotechnol."},{"key":"52400_CR65","doi-asserted-by":"publisher","first-page":"156","DOI":"10.2174\/1566523216666160524144041","volume":"16","author":"AT Das","year":"2016","unstructured":"Das, A. T., Tenenbaum, L. & Berkhout, B. Tet-on systems for Doxycycline-inducible gene expression. Curr. Gene Ther. 16, 156\u2013167 (2016).","journal-title":"Curr. Gene Ther."},{"key":"52400_CR66","doi-asserted-by":"publisher","first-page":"367","DOI":"10.1038\/nrg2775","volume":"11","author":"AS Khalil","year":"2010","unstructured":"Khalil, A. S. & Collins, J. J. Synthetic biology: applications come of age. Nat. Rev. Genet 11, 367\u2013379 (2010).","journal-title":"Nat. Rev. Genet"},{"key":"52400_CR67","doi-asserted-by":"publisher","first-page":"67","DOI":"10.2217\/fnl.15.3","volume":"10","author":"D Stanimirovic","year":"2015","unstructured":"Stanimirovic, D. & Kemmerich, K. Conquering the barriers: are antibody therapeutics feasible for CNS indications? Future Neurol. 10, 67\u201370 (2015).","journal-title":"Future Neurol."},{"key":"52400_CR68","first-page":"11","volume":"6","author":"JL Mikitsh","year":"2014","unstructured":"Mikitsh, J. L. & Chacko, A.-M. Pathways for small molecule delivery to the central nervous system across the blood-brain barrier. Perspect. Med. Chem. 6, 11\u201324 (2014).","journal-title":"Perspect. Med. Chem."},{"key":"52400_CR69","doi-asserted-by":"publisher","first-page":"101620","DOI":"10.1016\/j.xpro.2022.101620","volume":"3","author":"S Perriot","year":"2022","unstructured":"Perriot, S., Canales, M., Mathias, A. & Du Pasquier, R. Generation of transgene-free human induced pluripotent stem cells from erythroblasts in feeder-free conditions. STAR Protoc. 3, 101620 (2022).","journal-title":"STAR Protoc."},{"key":"52400_CR70","doi-asserted-by":"publisher","first-page":"246","DOI":"10.1016\/j.stem.2013.06.001","volume":"13","author":"N Yoshioka","year":"2013","unstructured":"Yoshioka, N. et al. Efficient generation of human iPSCs by a synthetic self-replicative RNA. Cell Stem Cell 13, 246\u2013254 (2013).","journal-title":"Cell Stem Cell"},{"key":"52400_CR71","doi-asserted-by":"publisher","first-page":"647","DOI":"10.1016\/j.stemcr.2015.08.015","volume":"5","author":"BA Baghbaderani","year":"2015","unstructured":"Baghbaderani, B. A. et al. cGMP-manufactured human induced pluripotent stem cells are available for pre-clinical and clinical applications. Stem Cell Rep. 5, 647\u2013659 (2015).","journal-title":"Stem Cell Rep."},{"key":"52400_CR72","doi-asserted-by":"publisher","DOI":"10.1038\/s41598-017-17204-5","volume":"7","author":"P Bankhead","year":"2017","unstructured":"Bankhead, P. et al. QuPath: Open source software for digital pathology image analysis. Sci. Rep. 7, 16878 (2017).","journal-title":"Sci. Rep."},{"key":"52400_CR73","doi-asserted-by":"crossref","unstructured":"Ciceri, G. et al. An epigenetic barrier sets the timing of human neuronal maturation. Nature 626, 881\u2013890 (2024).","DOI":"10.1038\/s41586-023-06984-8"},{"key":"52400_CR74","doi-asserted-by":"publisher","first-page":"113","DOI":"10.1016\/j.ymgme.2013.11.009","volume":"111","author":"L Ou","year":"2014","unstructured":"Ou, L., Herzog, T. L., Wilmot, C. M. & Whitley, C. B. Standardization of \u03b1-L-iduronidase enzyme assay with Michaelis-Menten kinetics. Mol. Genet Metab. 111, 113\u2013115 (2014).","journal-title":"Mol. Genet Metab."},{"key":"52400_CR75","doi-asserted-by":"publisher","first-page":"676","DOI":"10.1038\/nmeth.2019","volume":"9","author":"J Schindelin","year":"2012","unstructured":"Schindelin, J. et al. Fiji: an open-source platform for biological-image analysis. Nat. Methods 9, 676\u2013682 (2012).","journal-title":"Nat. Methods"},{"key":"52400_CR76","doi-asserted-by":"publisher","first-page":"10","DOI":"10.14806\/ej.17.1.200","volume":"17","author":"M Martin","year":"2011","unstructured":"Martin, M. Cutadapt removes adapter sequences from high-throughput sequencing reads. EMBnet. J. 17, 10\u201312 (2011).","journal-title":"EMBnet. J."},{"key":"52400_CR77","doi-asserted-by":"publisher","first-page":"15","DOI":"10.1093\/bioinformatics\/bts635","volume":"29","author":"A Dobin","year":"2013","unstructured":"Dobin, A. et al. STAR: ultrafast universal RNA-seq aligner. Bioinformatics 29, 15\u201321 (2013).","journal-title":"Bioinformatics"},{"key":"52400_CR78","doi-asserted-by":"publisher","first-page":"2078","DOI":"10.1093\/bioinformatics\/btp352","volume":"25","author":"H Li","year":"2009","unstructured":"Li, H. et al. The Sequence Alignment\/Map format and SAMtools. Bioinformatics 25, 2078\u20132079 (2009).","journal-title":"Bioinformatics"},{"key":"52400_CR79","doi-asserted-by":"publisher","DOI":"10.1186\/s12859-018-2353-5","volume":"19","author":"RJC Kluin","year":"2018","unstructured":"Kluin, R. J. C. et al. XenofilteR: computational deconvolution of mouse and human reads in tumor xenograft sequence data. BMC Bioinforma. 19, 366 (2018).","journal-title":"BMC Bioinforma."},{"key":"52400_CR80","doi-asserted-by":"publisher","unstructured":"Putri, G. H., Anders, S., Pyl, P. T., Pimanda, J. E. & Zanini, F. Analysing high-throughput sequencing data in Python with HTSeq 2.0. Bioinformatics btac166 https:\/\/doi.org\/10.1093\/bioinformatics\/btac166 (2022).","DOI":"10.1093\/bioinformatics\/btac166"},{"key":"52400_CR81","unstructured":"SCANPY: large-scale single-cell gene expression data analysis | Genome Biology | Full Text. https:\/\/genomebiology.biomedcentral.com\/articles\/10.1186\/s13059-017-1382-0."},{"key":"52400_CR82","unstructured":"Massively parallel digital transcriptional profiling of single cells | Nature Communications. https:\/\/www.nature.com\/articles\/ncomms14049."},{"key":"52400_CR83","doi-asserted-by":"crossref","unstructured":"Satopaa, V., Albrecht, J., Irwin, D. & Raghavan, B. Finding a \u2018Kneedle\u2019 in a Haystack: Detecting knee points in system behavior. 2011 31st International Conference on Distributed Computing Systems Workshops, Minneapolis, USA, 2011, pp. 166\u2013171 (2010).","DOI":"10.1109\/ICDCSW.2011.20"}],"container-title":["Nature Communications"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s41467-024-52400-8.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41467-024-52400-8","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41467-024-52400-8.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,9,18]],"date-time":"2024-09-18T08:22:17Z","timestamp":1726647737000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41467-024-52400-8"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,9,16]]},"references-count":83,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2024,12]]}},"alternative-id":["52400"],"URL":"https:\/\/doi.org\/10.1038\/s41467-024-52400-8","relation":{},"ISSN":["2041-1723"],"issn-type":[{"value":"2041-1723","type":"electronic"}],"subject":[],"published":{"date-parts":[[2024,9,16]]},"assertion":[{"value":"30 May 2024","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"2 September 2024","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"16 September 2024","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"All authors are current or past employees of BlueRock Therapeutics and have financial incentives to develop cellular medicines to reverse devastating diseases. All research was performed using BlueRock\u2019s internal funds. BlueRock is a wholly-owned subsidiary of Bayer AG. There are no more competing interests.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"8132"}}